AnPac Bio-Medical Science Co., Ltd.
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. AnPac Bio-Medical Science Co., Ltd.'s past years’ income statements indicate that its last revenue has decreased compared to the previous period by 33% to $12,044,000. The net income raised on -$103,598,000 and profit margin reached -860%. Total operating expenses were $92,474,000.
Profit Margin
| 2017 | 5.68M | -39.07M | -687.23% |
|---|---|---|---|
| 2018 | 10.25M | -42.06M | -410.37% |
| 2019 | 10.84M | -101.62M | -937.03% |
| 2020 | 20.50M | -80.56M | -392.83% |
| 2021 | 17.98M | -120.08M | -667.67% |
| 2022 | 12.04M | -103.59M | -860.16% |
ANPC Income Statement (2017 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|
Revenue | ||||||
Revenue | 12.04M | 17.98M | 20.50M | 10.84M | 10.25M | 5.68M |
Cost of revenue | 3.70M | 5.73M | 7.62M | 6.04M | 5.67M | 3.95M |
Gross profit | 8.33M | 12.25M | 12.88M | 4.79M | 4.57M | 1.73M |
Operating exp. | ||||||
Research and development | 9.53M | 16.20M | 11.57M | 9.83M | 10.10M | 11.40M |
Selling and marketing | 12.15M | 21.42M | 19.67M | 13.63M | 9.82M | 6.49M |
Total operating expenses | 92.47M | 118.3M | 106.00M | 93.88M | 48.18M | 42.65M |
Operating income | -84.13M | -106.04M | -93.12M | -89.08M | -43.60M | -40.92M |
Other income (expenses), net | -21.59M | -15.22M | 13.90M | -12.75M | 1.11M | 1.61M |
Income before tax | -105.72M | -121.26M | -80.65M | -101.83M | -42.49M | -39.31M |
Income tax expense | -2.13M | -1.18M | -88K | -218K | -199K | 9K |
Net income | -103.59M | -120.08M | -80.56M | -101.62M | -42.06M | -39.07M |
Earnings per share | ||||||
Basic EPS | -54.18 | -176.53 | -143.99 | -205.96 | -3.76 | -3.49 |
Diluted EPS | -54.18 | -176.53 | -143.99 | -205.96 | -3.76 | -3.49 |
| Data source | Data source | Data source | Data source |